Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (51) AK-Con-A (naphazoline ophthalmic), Akorn,
...Name: AK-Con-A (naphazoline ophthalmic) Company: Akorn Approval Status: Approved January 1996 Treatment Area: antihistamine product General Information The over-the-counter version of AK-Con-A (naphazoline ophthalmic) has been approved as a vasoconstrictor/antihistamine product for opthalmic use. Naphazoline ophthalmic causes decongestion in the eye by constricting blood vessels ...
View Page

2.  Study Posting (4107) Trial #131516, Allergy, Wildomar, CA
...Allergies or Hives? Children needed for an Outpatient Clinical Research Study with a new investigational antihistamine Criteria for participation: • 1 to 5 years of age • Suffering from sneezing, runny nose, itchy ...
View Page

3.  Newly Approved Drug Therapies (57) OcuHist, Pfizer,
...redness of the eye General Information OcuHist has been approved as an over-the-counter antihistamine eye drop. Akorn, previously marketed this formulation as the prescription drug AK-Con-A. With its active antihistamine ingredient pheniramine maleate (0.3%), and decongestant ingredient naphazoline hydrochloride (0.025%), OcuHist temporarily relieves ...
View Page

4.  Study Posting (4107) Trial #131517, Hives (Urticaria), Wildomar, CA
...Allergies or Hives? Children needed for an Outpatient Clinical Research Study with a new investigational antihistamine Criteria for participation: • 1 to 5 years of age • Suffering from sneezing, runny nose, itchy ...
View Page

5.  Newly Approved Drug Therapies (982) Patanase (olopatadine hydrochloride), Alcon,
...Approval Status: Approved April 2008 Treatment Area: seasonal allergic rhinitis General Information Patanase is an antihistamine with selective H1 -receptor antagonist activity: its principal effects are mediated via inhibition of H1 ...
...Pharyngolaryngeal Pain • Post-nasal drip • Cough • Urinary tract infection Mechanism of Action Patanase is an antihistamine with selective H1 -receptor antagonist activity: its principal effects are mediated via inhibition of H1 ...
View Page

6.  Newly Approved Drug Therapies (694) Tavist (clemastine fumarate), Novartis,
...eyes. Tavist Allergy/Sinus/Headache is the only over-the-counter medication to combine the antihistamine clemastine fumarate with a nasal decongestant and pain reliever. Side Effects General adverse events associated with the use of an analgesic, antihistamine, decongestant combination medication may include (but are not limited to) the following: • • Drowsiness • Nausea • Stomach ...
View Page

7.  Newly Approved Drug Therapies (5) Zyrtec (cetirizine HCl), Pfizer,
...December 1995 Treatment Area: allergy General Information In Europe, Zyrtec is the most widely prescribed antihistamine. It is currently used in more than 90 countries. Zyrtec is characterized by a fast ...
View Page

8.  Newly Approved Drug Therapies (175) Claritin Syrup (loratadine), Schering-Plough,
...seasonal allergies in children General Information Claritin Syrup has been approved as a non-drowsy antihistamine syrup for children as young as six years of age. In addition, the indication for ...
View Page

9.  Newly Approved Drug Therapies (885) Naglazyme (galsulfase), BioMarin Pharmaceuticals,
...kg once weekly via 4+ hour infusion, with pretreatment 30 to 60 minutes prior with antihistamines (with or without antipyretics) to reduce potential infusion reactions Clinical Results FDA Approval Approval of ...
...infusion reactions, some of which were severe. It is recommended that patients receive treatment with antihistamines with or without antipyretics prior to infusion, but this pretreatment is not entirely effective in ...
View Page

10.  Newly Approved Drug Therapies (177) Tavist (clemastine fumarate), Sandoz Pharmaceuticals,
...sneezing and runny nose. The FDA decision results from well-controlled clinical studies of the antihistamine clemastive fumarate, the active ingredient that differentiates the Tavist product from others. Jobson Medical Information ...
View Page

11.  Study Posting (418) Trial #160900, Emphysema, St. Louis, MO
...more than 15 hours per day • Serious uncontrolled conditions • Patients with allergic rhinitis that require antihistamines as needed Monica Shutz, Recruiter The Clinical Research Center, LLC 1040 North Mason Suite 112 ...
View Page

12.  Study Posting (418) Trial #160899, COPD (Chronic Obstructive Pulmonary Disease), St. Louis, MO
...more than 15 hours per day • Serious uncontrolled conditions • Patients with allergic rhinitis that require antihistamines as needed Monica Shutz, Recruiter The Clinical Research Center, LLC 1040 North Mason Suite 112 ...
View Page

13.  Study Posting (418) Trial #160901, Chronic Bronchitis, St. Louis, MO
...more than 15 hours per day • Serious uncontrolled conditions • Patients with allergic rhinitis that require antihistamines as needed Monica Shutz, Recruiter The Clinical Research Center, LLC 1040 North Mason Suite 112 ...
View Page

14.  Newly Approved Drug Therapies (159) Claritin-D 24 Hour Extended Release Tablets (10 mg loratadine, 240 mg pseudoephedrine sulfate), Schering-Plough,
...loratadine, 240 mg pseudoephedrine sulfate), a new once-daily formulation of the widely prescribed nonsedating antihistamine/decongestant combination Claritin-D (5 mg loratadine, 120 mg pseudoephedrine sulfate), has been approved for ...
View Page

15.  Newly Approved Drug Therapies (747) Clarinex, Schering-Plough,
...in adults and children over 12 years old. Clarinex is a once-daily non-sedating antihistamine that provides 24 hour relief. An estimated 45 million Americans are affected by allergies. Allergic ...
View Page

16.  Study Posting (77) Trial #150300, Eye Disorders/Infections, New York, NY
...doxycycline, or autologous serum within the previous 30 days or during the study; topical ocular antihistamines or topical or nasal vasoconstrictors within the previous 3 days or during the study; artificial ...
View Page

17.  Study Posting (1570) Trial #155218, Melanoma, Morristown, NJ
...Patient with severe allergic reactions to iodine contrast, which cannot be controlled by premedication with antihistamines and steroids (because a hepatic angiogram is needed for the Delcath System procedure). Exclusion: Patients ...
View Page

18.  Newly Approved Drug Therapies (953) Torisel (temsirolimus), Wyeth,
...sodium chloride injection. Patients should receive prophylactic intravenous diphenhydramine 25 to 50 mg (or similar antihistamine) approximately 30 minutes before the start of each dose. The concomitant use of strong CYP3A4 ...
View Page

19.  CenterWatch Clinical Research Profile (2828) Trial #1352, Women's Diagnostics, San Antonio, TX
...TKL Research Our center specializes in clinical trials for: • Abdominal Pain • Allergic Rhinitis • Allergy Medications • Antihistamines • Antibiotics • Antihypertensives • Asthma • BCP’s • Bronchodilators • COPD • Cholesterol Studies • Complicated Hypertension • Diabetes • Diagnosis of Carcinoma ...
...and Pulmonary Medicine Investigator: • Acute Exacerbation of Chronic Bronchitis • Allergic Rhinitis • Allergy/Asthma Study of Antihistamine • Antibiotic Study of the Treatment of Community-Acquired Pneumonia • Antibiotic Study of the Treatment of ...
View Page

20.  CenterWatch Clinical Research Profile (1212) Trial #603, Lung Diagnostics, LTD, San Antonio, TX
...Research Our center specializes in clinical trials for: • Abdominal Pain • Allergic Rhinitis • Allergy Medications • Antibiotics • Antihistamines • Antihypertensives • Asthma • BCP’s • Bronchodilators • COPD • Cholesterol Studies • Complicated Hypertension • Diabetes • Diagnosis of Carcinoma • Dyspepsia ...
...and Pulmonary Medicine Investigator: • Acute Exacerbation of Chronic Bronchitis • Allergic Rhinitis • Allergy / Asthma Studies of Antihistamine • Antibiotic Studies of the Treatment of Community-Acquired Pneumonia • Antibiotic Studies of the Treatment of ...
View Page